Investment
Cradle Genomics
Cradle Genomics engineers next-generation prenatal diagnostic tests that combine genomics with proprietary biochemistry.
Highlights
- Investment supports the shift toward safer, noninvasive prenatal testing.
- Cradle’s platform exemplifies Don’s interest in applying engineering rigor to medical diagnostics.